| Effect | Decrease |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 78 |
| Sex | Both Genders |
| Age Range | 30-44, 45-64 |
| Body Types | Average |
Low dose chromium supplementation (23.3mcg) via Brewer's Yeast and 200mcg chromium as trichloride for eight weeks in type II diabetics both appeared to reduce both fasting and postprandial blood glucose (75g glucose tolerance test) and was able to reduce fructosamine as well.
